Edition:
United Kingdom

Curis Inc (CRIS.OQ)

CRIS.OQ on NASDAQ Stock Exchange Global Market

1.45USD
12 Nov 2018
Change (% chg)

$-0.00 (-0.00%)
Prev Close
$1.45
Open
$1.56
Day's High
$1.56
Day's Low
$1.45
Volume
40,113
Avg. Vol
39,195
52-wk High
$6.05
52-wk Low
$1.36

Latest Key Developments (Source: Significant Developments)

Curis Reports Third Quarter 2018 Financial Results
Thursday, 1 Nov 2018 

Nov 1 (Reuters) - Curis Inc ::CURIS REPORTS THIRD QUARTER 2018 FINANCIAL RESULTS.Q3 LOSS PER SHARE $0.22.Q3 REVENUE $2.8 MILLION VERSUS I/B/E/S VIEW $2.4 MILLION.Q3 EARNINGS PER SHARE VIEW $-0.30 -- THOMSON REUTERS I/B/E/S.SAYS RE-ALLOCATING RESOURCES TO PRIORITIZE CLINICAL OPERATIONS AND HAVE IMPLEMENTED A REDUCTION IN HEADCOUNT AND EXPENDITURE.SAYS EXPECT REDUCTIONS WILL OFFSET INCREASE IN HEADCOUNT AND COSTS ASSOCIATED WITH CLINICAL OPERATIONS AND RESULT IN NET SAVINGS FOR CO.  Full Article

Curis Inc Says James Dentzer Became COO And CFO Of Co
Thursday, 22 Mar 2018 

March 22 (Reuters) - Curis Inc ::CURIS SAYS ON MARCH 21, JAMES DENTZER BECAME CHIEF OPERATING OFFICER AND CFO OF CO - SEC FILING.CURIS INC - DENTZER BECAME CFO IN CONNECTION WITH ENTRANCE INTO AN AMENDED AND RESTATED EMPLOYMENT AGREEMENT.  Full Article

Curis Q4 Loss Per Share $0.05
Thursday, 8 Mar 2018 

March 8 (Reuters) - Curis Inc ::CURIS REPORTS FOURTH QUARTER AND YEAR-END 2017 FINANCIAL RESULTS.Q4 REVENUE $3.3 MILLION.Q4 LOSS PER SHARE $0.05.  Full Article

Curis Inc says Q3 loss per share $0.11
Tuesday, 7 Nov 2017 

Nov 7 (Reuters) - Curis Inc -:Curis reports third quarter 2017 financial results.Q3 revenue $2.4 million versus I/B/E/S view $2.2 million.Q3 loss per share $0.11.Q3 earnings per share view $-0.09 -- Thomson Reuters I/B/E/S.Curis Inc - ‍announce Acceptance Of Investigational New Drug (IND) application for CA-4948​.  Full Article

Curis announces pricing of public offering of common stock
Thursday, 14 Sep 2017 

Sept 14 (Reuters) - Curis Inc :Curis Inc - pricing of an underwritten public offering of 20 million shares of its common stock​.  Full Article

Curis announces proposed public offering of common stock
Wednesday, 13 Sep 2017 

Sept 13 (Reuters) - Curis Inc :Curis announces proposed public offering of common stock.Curis Inc says ‍intention to offer and sell up to 20 million shares of its common stock in an underwritten public offering.Curis Inc- Intends to use net proceeds to continue development of CUDC-907, as well as CA-170, CA-327 and CA-4948.  Full Article

Curis reports Q2 loss per share $0.10
Thursday, 3 Aug 2017 

Aug 3 (Reuters) - Curis Inc :Curis reports second quarter 2017 financial results.Q2 revenue $2.1 million versus i/b/e/s view $2.1 million.Q2 loss per share $0.10.Q2 earnings per share view $-0.09 -- Thomson Reuters I/B/E/S.  Full Article

Cara Therapeutics appoints Mani Mohindru CFO
Tuesday, 1 Aug 2017 

Aug 1 (Reuters) - Cara Therapeutics Inc ::Cara Therapeutics appoints Mani Mohindru, Ph.D., chief financial officer.Josef Schoell, who has held CFO position at Cara for more than a decade, will be retiring.Most recently, Mohindru served as chief strategy officer at Curis, Inc.  Full Article

Curis Q1 loss per share $0.11
Thursday, 4 May 2017 

May 4 (Reuters) - Curis Inc :Curis reports first quarter 2017 financial results.Q1 revenue $2.1 million versus i/b/e/s view $2 million.Q1 loss per share $0.11.Q1 earnings per share view $-0.09 -- Thomson Reuters I/B/E/S.Curis inc qtrly loss per share $0.11.Curis inc - revenues for q1 of 2017 were $2.1 million as compared to $1.7 million for same period in 2016.  Full Article

Curis Q4 loss per share $0.08
Thursday, 9 Mar 2017 

Curis Inc : Curis reports fourth quarter and year-end 2016 financial results . Q4 revenue $2.4 million . Q4 revenue view $1.9 million -- Thomson Reuters I/B/E/S . Q4 loss per share $0.08 . Q4 earnings per share view $-0.10 -- Thomson Reuters I/B/E/S .Curis inc - company announces $45 million debt transaction with healthcare royalty partners secured with future erivedge(®) royalty.  Full Article